0001683168-23-007110.txt : 20231012 0001683168-23-007110.hdr.sgml : 20231012 20231012180115 ACCESSION NUMBER: 0001683168-23-007110 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230921 FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans Carl Anthony CENTRAL INDEX KEY: 0001792582 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 231323509 MAIL ADDRESS: STREET 1: C/O CNS PHARMACEUTICALS, INC. STREET 2: 2100 WEST LOOP SOUTH STE 900 CITY: HOUSTON STATE: TX ZIP: 77027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4/A 1 ownership.xml X0508 4/A 2023-09-21 2023-09-25 0 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001792582 Evans Carl Anthony C/O CNS PHARMACEUTICALS, INC. 100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 1 0 0 0 0 Option to purchase common stock 1.09 2023-09-21 4 A 0 39475 A 2033-09-22 Common Stock 39475 45428 D The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date. The stock options were issued in connection with the reporting person's Board of Director services to the Company. This amendment is being filed solely to correct the number of shares of common stock underlying the reported option, and total number of derivative securities owned following the reported transaction. /s/ Christopher Downs, Attorney-in-fact 2023-10-12